|
|
Effect of Dopamine and Phentolamine in emergency severe pneumonia with heart failure |
LU Jian-guang |
Department of Emergency,the Hospital of Shunyi District of Beijing,Beijing 101300,China |
|
|
Abstract Objective To analyze the effect of Dopamine and Phentolamine in emergency severe pneumonia with heart failure.Methods A total of 54 children with severe pneumonia complicated with heart failure treated in the Hospital of Shunyi District of Beijing from February 2018 to February 2020 were selected as the research subjects.According to random number table method,they were divided into control group (27 cases) and experimental group (27 cases).The control group was treated with Dopamine,and the experiment group was treated with the combination of Dopamine and Phentolamine.The clinical total effective rates,inflammatory factor levels and cardiac functions of the two groups were compared.Results The total effective rate of the experiment group was higher than that of the control group,with statistically significant difference (P<0.05).Before treatment,the differences of C-reactive protein (CRP),tumor necrosis factor α (TNF-α),interleukin-6 (IL-6) levels between the two groups were not statistically significant (P>0.05).After treatment,the levels of CRP,TNF-α and IL-6 in the two groups were lower than those before treatment,while the levels of CRP,TNF-α and IL-6 in the experimental group were lower than those in the control group,with statistically significant differences (P<0.05).After treatment,the heart rate and left ventricular end diastolic diameter of the two groups were lower than those before treatment,and the left ventricular ejection fraction was higher than that before treatment,and the differences were statistically significant (P<0.05).Heart rate and left ventricular end diastolic diameter in experimental group were lower than those in control group,and left ventricular ejection fraction was higher than that in control group,with statistically significant differences (P<0.05).Conclusion Dopamine and Phentolamine was more effective than monotherapy in the treatment of emergency severe pneumonia with heart failure.
|
|
|
|
|
[1] |
廖霓,张国英,熊梓宏,等.美托洛尔联合多巴胺对重症肺炎伴心力衰竭患儿的临床疗效研究[J].河北医学,2018,24(6):987-991.
|
[2] |
黄妮娜,高晓鹏,章玉丹,等.多巴胺联合酚妥拉明治疗小儿重症肺炎合并心衰疗效研究[J].现代生物医学进展,2017,17(12):2302-2305.
|
[3] |
Tang L,Li Q,Bai J,et al.Severe pneumonia mortality in pediatric patients is associated with downregulation of Tolllike receptors 2 and 4 on monocytes[J].Am J Med Sci,2014,347(1):34-41.
|
[4] |
中华医学会儿科学分会呼吸组,刘传合,向莉,等.第13届全国儿科呼吸系统疾病学术会议纪要[J].中华儿科杂志,2013,51(2):115-116.
|
[5] |
李煜琳.多巴胺联合酚妥拉明治疗西宁地区小儿重症肺炎并心力衰竭的疗效观察[J].青海医药杂志,2016,46(1):20-21.
|
[6] |
王瑞娟,孟牛安,王宏磊,等.酚妥拉明联合多巴胺治疗小儿重症肺炎疗效及对相关血清指标的影响[J].首都食品与医药,2020,27(1):87.
|
[7] |
陈玲.多巴胺联合酚妥拉明对小儿肺炎合并心力衰竭的临床疗效研究以及心肌酶谱的影响[J].临床急诊杂志,2016,17(2):154-156.
|
[8] |
李茸茸,祁婧.纳洛酮联合激素治疗小儿重症肺炎合并心力衰竭65例临床观察[J].陕西医学杂志,2017,46(8):1117-1118.
|
[9] |
宋道兵.小剂量多巴胺与多巴酚丁胺联合辅助治疗对重症肺炎患儿血清免疫球蛋白、白介素-4、肿瘤坏死因子水平的影响[J].中国妇幼保健,2018,33(1):112-114.
|
[10] |
张向峰,靳秀红.多巴胺联合美托洛尔治疗小儿肺炎合并心力衰竭66例的疗效及对心脏结构的影响[J].安徽医药,2018,22(7):1388-1391.
|
[11] |
周晓娜.血必净注射液联合多巴酚丁胺和酚妥拉明治疗重症肺炎合并心力衰竭的临床研究[J].现代药物与临床,2018,33(3):507-512.
|
[12] |
焦方刚.喜炎平注射液联合酚妥拉明治疗重症肺炎的临床研究[J].现代药物与临床,2019,34(11):3280-3283.
|
[13] |
邹莹波,杨嫚,赵兴艳,等.盐酸溴已新联合酚妥拉明对重症肺炎患儿感染症状的控制效果[J].中国地方病防治杂志,2017,32(8):929,931.
|
[14] |
周琳.酚妥拉明联合多巴胺和多巴酚丁胺治疗小儿重症肺炎合并呼吸衰竭的临床研究[J].现代药物与临床,2017,32(8):1499-1503.
|
[15] |
赵荣香,任丹,吴培,等.小儿重症肺炎并呼吸衰竭予小剂量多巴胺、多巴酚丁胺联合酚妥拉明治疗的临床疗效研究[J].中国妇幼健康研究,2017,28(S2):493-494.
|
|
|
|